Pfizer (XSWX:PFE) Interest Expense: CHF-2,143 Mil (TTM As of Mar. 2026)

What is Pfizer Interest Expense?

Pfizer XSWX:PFE 59 Interest Expense is CHF-2,143 Mil as of Mar. 2026. GuruFocus rates XSWX:PFE with a GF Score™ of 59/100 and a GF Value™ of CHF21.05 (Fairly Valued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pfizer's interest expense for the three months ended in Mar. 2026 was CHF -526 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-2,143 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pfizer's Operating Income for the three months ended in Mar. 2026 was CHF 3,360 Mil. Pfizer's Interest Expense for the three months ended in Mar. 2026 was CHF -526 Mil. Pfizer's Interest Coverage for the quarter that ended in Mar. 2026 was 6.39. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pfizer (XSWX:PFE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pfizer's Interest Expense for the three months ended in Mar. 2026 was CHF-526 Mil. Its Operating Income for the three months ended in Mar. 2026 was CHF3,360 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was CHF47,112 Mil.

Pfizer's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	3360.196	/	-525.916
	=	6.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Pfizer Interest Expense Historical Data

* Premium members only.

The historical data trend for Pfizer's Interest Expense can be seen below:

Pfizer Interest Expense Chart

Pfizer Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-1,189.01

-1,153.32

-1,910.34

-2,755.94

-2,128.52

Pfizer Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-577.87	-531.83	-519.06	-566.60	-525.92

59GF Score

Pfizer Inc XSWX:PFE

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Pfizer Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-2,143 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of CHF-2,143 Mil mean?

Pfizer (XSWX:PFE) has a Interest Expense of CHF-2,143 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pfizer and its competitors.

Is Pfizer's Interest Expense too high?

Pfizer's current Interest Expense is CHF-2,143 Mil. Overall, Pfizer has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Pfizer's Interest Expense compare to GILD and BMY?

Pfizer's Interest Expense of CHF-2,143 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pfizer and its competitors. Pfizer's current Interest Expense is CHF-2,143 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pfizer stock overvalued right now?

Based on GuruFocus' analysis, Pfizer (XSWX:PFE) is currently considered Fairly Valued. The stock's GF Value™ is CHF21.05, compared to a current price of CHF19.62 — trading 6.8% below its estimated fair value. The current Interest Expense is CHF-2,143 Mil. Pfizer's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Pfizer (XSWX:PFE), the current Interest Expense is CHF-2,143 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (XSWX:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of CHF19.62 is trading 6.8% below its estimated GF Value™ of CHF21.05. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for XSWX:PFE:

Interest Expense: CHF-2,143 Mil
GF Value™: CHF21.05 vs. price of CHF19.62 (6.8% below fair value)
GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the XSWX:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies GILD BMY AMGN BIIB MRK OGN AMRN SCLX MIRA NSRX LLY JNJ ABBV XSWX:ROP LSE:AZN XSWX:NOVN OCSE:NOVO B XPAR:SAN LSE:GSK TSE:4519

Other Exchanges PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFECO:Colombia PFE:Chile ZPFE:Canada PFE:Canada PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

59GF Score

Get the complete analysis for XSWX:PFE

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF19.62

Price

CHF21.05

GF Value

View XSWX:PFE Analysis

See Interest Expense data for all stocks →